Highmark Medicare Services - A CMS Contractor - ISO 9001:2000 Certified
Basic Search >
 
NOTE: This is a PREVIOUS VERSION. A more current version of this document is available.

Contractor Information

Contractor Name:

Highmark Medicare Services

Contractor Number:

12102, 12202, 12302

Contractor Type:

MAC Part A & B

LCD Information

LCD Database ID Number

L27512

LCD Title

Paravertebral Facet Joint Nerve Block and Sacroiliac Joint Injection

Contractor’s Determination Number

L27512

AMA CPT/ADA CDT Copyright Statement

CPT codes, descriptions and other data only are copyright 2007 American Medical Association (or such other date of publication of CPT). All Rights Reserved. Applicable FARS/DFARS Clauses Apply. Current Dental Terminology, (CDT) (including procedure codes, nomenclature, descriptors and other data contained therein) is copyright by the American Dental Association. © 2002, 2004 American Dental Association. All rights reserved. Applicable FARS/DFARS apply.

CMS National Coverage Policy

Title XVIII of the Social Security Act, Section 1862(a)(1)(A) states that no Medicare payment shall be made for items or services which are not reasonable and necessary for the diagnosis or treatment of illness or injury.

Title XVIII of the Social Security Act, Section 1862(a)(7). This section excludes routine physical examinations.

Title XVIII of the Social Security Act, Section 1833(e) states that no payment shall be made to any provider for any claim that lacks the necessary information to process the claim.

Primary Geographic Jurisdiction

Maryland, District of Columbia, Delaware

Oversight Region

Central Office

Original Determination Effective Date

For services performed on or after 07/11/2008

Original Determination Ending Date

N/A

Revision Effective Date

For services performed on or after N/A

Revision Ending Date

N/A

Indications and Limitations of Coverage and/or Medical Necessity

Compliance with the provisions in this policy may be monitored and addressed through post payment data analysis and subsequent medical review audits.

Paravertebral Facet Joint Block

Paravertebral facet joint block is used to both diagnose and treat lumbar zygapophysial (facet joint) pain. Facet joint pain syndrome is a challenging diagnosis as there are no specific history, physical examination, or radiological imaging findings that point exclusively to the diagnosis. However, this diagnosis is considered if the patient describes nonspecific, achy, low back pain that is located deep in the paravertebral area. A detailed physical examination of the spine should be performed on all patients. Radiological imaging is often done as part of the workup of persistent chronic back pain to exclude other diagnoses.

Facet joint block is one method used to document/confirm suspicions of posterior elemental biomechanical pain of the spine. Often the patient presents with chronic neck, thoracic or back pain that lacks a strong radicular component, has no associated neurologic deficits, and is often aggravated by hyperextension or rotation of the spine. This policy defines chronic pain as continuous or intermittent pain that has been unresponsive to conservative measures, persisting three months or more.

Facet joint injections must be performed under fluoroscopic guidance to assure accurate placement of the needle in the facet joint or on the medial nerve branch of the facet joint. A long acting local anesthetic or corticosteroid agent is injected to temporarily denervate the facet joint. After a satisfactory block has been obtained, the patient is asked to indulge in the activities that usually aggravated his/her pain and to record his/her impressions of the effect of the procedure 4-8 hours after the injection. Temporary or prolonged abolition of the spinal pain suggests that facet joints were the source of the symptoms.

Sacroiliac Injections

Similarly injections of the sacroiliac joint may be used to diagnose the cause of or to treat low back pain.

The sacroiliac (SI) joint is formed by the articular surfaces of the sacrum and iliac bones. Anatomically and biomechanically, the sacroiliac joint shares all its muscles with the hip joint and is thus subject to the unidirectional pelvic shear, repetitive and torsional forces which can contribute to SI joint pain.

Pain arising from the SI joint may mimic pain originating from the lumbar disc, lumbar facet, or hip joint. Additionally, pain coming from the SI joint is not confined to originate only from the joint; it can comprise both intra and extraarticular structures. Except in the presence of clear pathology (tumor, fracture, infection), clinical diagnosis of SI joint pain is difficult and often one of exclusion.

Indications

Paravertebral Facet Joint Blocks

The decision to treat chronic pain by invasive procedures must be based on a systematic assessment of the location, intensity, and pathophysiology of the pain. The pain must have been present for greater than 3 months. A detailed pain history is essential and must provide detail about prior treatments and responses which may include but not be limited to analgesics and physical therapy.

Paravertebral facet nerve blocks have both diagnostic and therapeutic functions.

Diagnostic blocks:

Diagnostic blocks are used to assess the relative contribution of sympathetic and somatosensory nerves in relation to the pain syndrome and to localize the nerve(s) responsible for the pain or neuromuscular dysfunction particularly when multiple sources of pain are potentially present.

Diagnostic blocks are usually administered in two sessions one to two weeks apart. During the first session a short-acting anesthetic is used and during the second session a long-acting anesthetic is used. The patient then records their response to pain. If the relief of pain response time correlates with the type of anesthetic used, then the diagnosis of paravertebral facet pain can be made.

Therapeutic blocks:

Therapeutic blocks are performed after the diagnosis is established. These blocks typically include the use of anesthetic or corticosteroid substances for the long-term control of pain.

A series of injections may be medically necessary to establish consistency of results, particularly if diagnostic blocks are to be followed by neurolysis. If successful, it is reasonable to repeat this series for a relapse. However, long term multiple nerve blocks over a period of several weeks or months is not an effective method of chronic pain management, therefore; it is not generally considered reasonable and necessary to perform facet joint nerve blocks more than (4) injections per level, per year.

Fluroscopic guidance must be used for both diagnostic and therapeutic injections to assure that the injection is properly placed.

Sacroiliac Injections

The differential diagnosis of SI joint pain requires a detailed history and thorough physical exam. Imaging with radiographs, MRI, bone scans, and CT scans do not consistently differentiate symptomatic from asymptomatic individuals.

SI joint injection can be used diagnostically or therapeutically. These are defined as follows:

  • Diagnostic injections -- either an anesthetic is injected for immediate pain relief or contrast media is injected into the joint for evaluation of the integrity (or lack thereof) of the articular cartilage and morphologic features of the joint space and capsule.
  • Therapeutic indications -- a steroid is injected into the SI joint for immediate and potentially lasting pain relief.

Fluoroscopic guidance ensures optimal access to the SI joint space in diagnostic procedures but may not be necessary for therapeutic SI injections.

When sacroiliac joint dysfunction is present in conjunction with other primary pain generators (such as lumbar radiculitis secondary to degenerative disc disease or lumbar facet arthropathy secondary to lumbar facet arthritis), treatment should first address the non-sacroiliac joint pain generators, as SI joint dysfunction may resolve once these pain generators have been successfully treated. If there is residual sacrolilac joint pain, it may be appropriate to perform SI joint injections to address the remaining pain.

Limitations

Once a diagnostic paravertebral block is negative at a specific level, no repeat interventions should be directed at that level unless there is a new clinical presentation with symptoms, signs, and diagnostic studies of known reliability and validity that implicate that level.

Therapeutic paravertebral nerve blocks exceeding two levels (bilaterally) on the same day will be denied as medically unnecessary.

Multiple paravertebral facet nerve blocks administered over a period of several weeks or months is not an effective method of chronic pain management and will be denied as not medically necessary. Facet joint blocks administered more frequently than four injections/spinal level/side will be denied as medically unnecessary.

Repeat therapeutic paravertebral nerve blocks at the same level, in the absence of a prior response demonstrating >50% relief of pain lasting at least six weeks, will be denied as medically necessary.

If the documentation in the medical record substantiates that the SI injections are not effective, additional injections will be considered not medically necessary.

An epidural (62311), transforaminal epidural (64483, 64484), sacroiliac joint injection (27906), or lumbar sympathetic block (64520) should not be performed on the same day as facet joint nerve block injections. Furthermore, only one type of a block or injection should be performed in a given session so that the effectiveness of its treatment can be assessed prior to attempting another type of spinal block or injection.

Any procedure performed that does not meet the “Indications and Limitations of Coverage and/or Medical Necessity” section outlined in this policy.

Any procedure performed on a beneficiary that lacks a diagnosis listed in the “ICD-9 Codes That Support Medical Necessity” section of this policy.

Coverage Topic

Doctor Office Visits, Surgical Services

Coding Information

Bill Type Codes

Contractors may specify Bill Types to help providers identify those Bill Types typically used to report this service. Absence of a Bill Type does not guarantee that the policy does not apply to that Bill Type. Complete absence of all Bill Types indicates that coverage is not influenced by Bill Type and the policy should be assumed to apply equally to all claims.

11x

Hospital-inpatient (including Part A)

12x

Hospital-inpatient or home health visits (Part B only)

13x

Hospital-outpatient (HHA-A also) (under OPPS 13X must be used for ASC claims submitted for OPPS payment -- eff. 7/00)

83x

Special facility or ASC surgery-ambulatory surgical center (Discontinued for Hospitals Subject to Outpatient PPS; hospitals must use 13X for ASC claims submitted for OPPS payment -- eff. 7/00)

85x

Special facility or ASC surgery-rural primary care hospital (eff 10/94)

 

Revenue Codes

Contractors may specify Revenue Codes to help providers identify those Revenue Codes typically used to report this service. In most instances Revenue Codes are purely advisory; unless specified in the policy services reported under other Revenue Codes are equally subject to this coverage determination. Complete absence of all Revenue Codes indicates that coverage is not influenced by Revenue Code and the policy should be assumed to apply equally to all Revenue Codes.

032X

Radiology diagnostic-general classification

033X

Radiology therapeutic-general classification

049X

Ambulatory surgical care-general classification

051X

Clinic-general classification

 

CPT/HCPCS Codes

Italicized and/or quoted material is excerpted from the American Medical Association, Current Procedural Terminology (CPT) codes.

CPT/HCPCS Codes for Paravertebral Facet Joint Injections

64470

INJECTION, ANESTHETIC AGENT AND/OR STEROID, PARAVERTEBRAL FACET JOINT OR FACET JOINT NERVE; CERVICAL OR THORACIC, SINGLE LEVEL

64472

INJECTION, ANESTHETIC AGENT AND/OR STEROID, PARAVERTEBRAL FACET JOINT OR FACET JOINT NERVE; CERVICAL OR THORACIC, EACH ADDITIONAL LEVEL (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)

64475

INJECTION, ANESTHETIC AGENT AND/OR STEROID, PARAVERTEBRAL FACET JOINT OR FACET JOINT NERVE; LUMBAR OR SACRAL, SINGLE LEVEL

64476

INJECTION, ANESTHETIC AGENT AND/OR STEROID, PARAVERTEBRAL FACET JOINT OR FACET JOINT NERVE; LUMBAR OR SACRAL, EACH ADDITIONAL LEVEL (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)

CPT/HCPCS Codes for SI Joint Injections

27096

INJECTION PROCEDURE FOR SACROILIAC JOINT, ARTHROGRAPHY AND/ OR ANESTHETIC/STEROID

73542

RADIOLOGICAL EXAMINATION, SACROILIAC JOINT ARTHROGRAPHY, RADIOLOGICAL SUPERVISION AND INTERPRETATION

77003

FLUOROSCOPIC GUIDANCE AND LOCALIZATION OF NEEDLE OR CATHETER TIP FOR SPINE OR PARASPINOUS DIAGNOSTIC OR THERAPEUTIC INJECTION PROCEDURES (EPIDURAL, TRANSFORAMINAL EPIDURAL, SUBARACHNOID, PARAVERTEBRAL FACET JOINT, PARAVERTEBRAL FACET JOINT NERVE, OR SACROILIAC JOINT), INCLUDING NEUROLYTIC AGENT DESTRUCTION

G0260

INJECTION PROCEDURE FOR SACROILIAC JOINT; PROVISION OF ANESTHETIC, STEROID AND/OR OTHER THERAPEUTIC AGENT, WITH OR WITHOUT ARTHROGRAPHY

 

ICD-9 Codes that Support Medical Necessity

It is the provider’s responsibility to select codes carried out to the highest level of specificity and selected from the ICD-9-CM code book appropriate to the year in which the service is rendered for the claim(s) submitted.

These ICD-9-CM codes ONLY apply to the CPT/HCPCS Codes 64470, 64472, 64475, 64476.

721.0

CERVICAL SPONDYLOSIS WITHOUT MYELOPATHY

721.1

CERVICAL SPONDYLOSIS WITH MYELOPATHY

721.2

THORACIC SPONDYLOSIS WITHOUT MYELOPATHY

721.3

LUMBOSACRAL SPONDYLOSIS WITHOUT MYELOPATHY

721.41

SPONDYLOSIS WITH MYELOPATHY THORACIC REGION

721.42

SPONDYLOSIS WITH MYELOPATHY LUMBAR REGION

723.1

CERVICALGIA

724.2

LUMBAGO

847.0

NECK SPRAIN

847.1

THORACIC SPRAIN

847.2

LUMBAR SPRAIN

These ICD-9-CM codes ONLY apply to the CPT/HCPCS Codes 27096, 73542, 77003, G0260.

720.0

ANKYLOSING SPONDYLITIS

720.2

SACROILIITIS NOT ELSEWHERE CLASSIFIED

724.6

DISORDERS OF SACRUM

846.0 - 846.9

LUMBOSACRAL (JOINT) (LIGAMENT) SPRAIN - UNSPECIFIED SITE OF SACROILIAC REGION SPRAIN

 

Diagnoses that Support Medical Necessity

N/A

ICD-9 Codes that DO NOT Support Medical Necessity

All those not listed under the “ICD-9 Codes that Support Medical Necessity” section of this policy.

ICD-9 Codes that DO NOT Support Medical Necessity Asterisk Explanation

 

Diagnoses that DO NOT Support Medical Necessity

Conditions that are not listed in the "ICD-9-CM Codes that Support Medical Necessity" section of this policy.

General Information

Documentation Requirements

  1. All documentation must be maintained in the patient’s medical record and available to the contractor upon request.
  2. Every page of the record must be legible and include appropriate patient identification information (e.g., complete name, dates of service(s)). The record must include the physician or non-physician practitioner responsible for and providing the care of the patient.
  3. The submitted medical record should support the use of the selected ICD-9-CM code(s). The submitted CPT/HCPCS code should describe the service performed.
  4. The drugs injected, the doses used, the site of the injection and the response should all be documented in the patient’s medical record.

Specific Documentation Requirements for Paravertebral Facet Joint Injections:

  1. The patient’s medical record must indicate the medical necessity of services for each date of service billed. This must include the patient’s history (complete pain history and inclusion of failed conservative measures), physical examination and adequate follow-up documentation specific to patient response to the nerve blocks.
  2. The pre-procedure evaluation leading to suspicion of the presence of the facet joint pathology must be explicitly documented in the patient’s medical record along with the post procedure conclusions. All documentation must be available to Medicare upon request.

Specific Documentation Requirements for Sacroiliac Joint Injections:

  1. The medical record must provide the evaluation leading to a SI joint dysfunction diagnosis. In addition the extenuating circumstances (i.e. level of pain, interruption of activities of daily living), must be clearly documented.
  2. Notation that if the SI joint pain is secondary to another primary source of pain, treatment of the primary source has been performed prior to the initiation of the SI joint injection.
  3. Identification of the affected muscle(s), fascia and/or ligaments and the site of each injection noted.
  4. Indication that noninvasive treatments (i.e. rest, physical therapy, NSAIDs, etc.) have been tried and were unsuccessful or contraindicated.
  5. For subsequent treatments with SI joint injections, the documentation in the medical record must show the benefits received from the prior set(s) of injections.

 

Utilization Guidelines

In accordance with CMS Ruling 95-1 (V), utilization of these services should be consistent with locally acceptable standards of practice.

Evidence-based practice guidelines indicate the following descriptions of the frequency of paravertebral facet blocks and SI joint injections:

 

ParvertebralFacet Blocks

Sacroiliac Injections

Diagnostic

2 procedure maximum with procedures 1-2 weeks apart

2 procedure maximum with procedures 1-2 weeks apart

Therapeutic: frequency

1 every 2-3 months or greater providing there is a 50% pain relief for 6 weeks

1 every 2-3 months or greater providing there is a 50% pain relief for 6 weeks

Therapeutic: maximum number

Four injections/side/spinal level per year

Four injections/year /region

Paravertebral facet joint nerve blocks in excess of more than (4) injections/ level/per year, will be reviewed on an individual consideration basis.

Patients who have gained no symptom relief of functional improvement after two injections of the SI joint should not proceed with additional injections because the likelihood of pain relief after two failed attempts is low.

If the muscles surrounding the sacroiliac joint are injected in lieu of the joint, then a trigger point injection should be recorded and not a sacroiliac joint injection.

This contractor may request records when it is apparent that patients are requiring a significant number of injections to manage their pain.

 

Sources of Information and Basis for Decision

American Medical Association; CPT 2000 code and guideline changes: A comprehensive review. CPT Assistant. Nov.1999; 9 (11).

Boswell M.V., Shah R.V., Everett C.R., Sehgal N., Mckenzie-Brown A., Abdi S., Bowman R.C., Deer T.R., Datta S., Colson J.D., Spillane, W.F., Smith H.S., Lucas L.F., Burton A.W., Chopra P., Staats P.S., Wasserman R.A., and Manchikanti L.; Interventional techniques in the management of chronic spinal pain: evidence-based practice guidelines. Pain Physician. 2007; 10(1):7-111.

Cardone D.A., and Tallia A.F.; Joint and soft tissue injection. American Family Physician. Jul 15, 2002; 66(2): 283-288.

Carragee E.J., Hannibal M.; Diagnostic evaluation of low back pain. Orthopedic Clinics of North America. 2004; 35(1): 7-16.

CMS Change Request 2979.

Dussault R.G., Kaplan P.A., Anderson M.A.; Fluoroscopy-guided sacroiliac joint injections. Department of Radiology, University of Virginia Health System. Received November 19, 1998; revision requested December 21; final revision received April 16, 1999; accepted June 28 1999.

Elgafy H., Semaan H.B., Ebrahim N.A., Coombs R.J.; Computed tomography findings in patients with sacroiliac pain. Clinical Orthopaedics and Related Research. 2001;(382); 112-118.

Hansen H.C.; Fluoroscopy is necessary for accurate sacroiliac joint injection. Anesthesiology 2001; 95:A841.

Holm I, Friis A, Brox JI, Gunderson R, Steen H., Minimal influence of facet joint anesthesia on isokinetic muscle performance in patients with chronic degenerative low back disorders; Spine 2000 Aug 15; 25 (16): 2091-4.

Interventional techniques:  evidence-based practice guidelines in the management of chronic spinal pain.  Accesses on January 7, 2008 at www.guideline.gov.

Kim PS, Role of injection therapy: review of indications for trigger point injections, regional blocks, facet joint injections, and intra-articular injections; Curr Opin Rheumatol. 2002 Jan;14 (1):52-7.

Manchikanti L., Facet Joint Pain and the Role of Neural Blockade in Its Management; Curr Rev Pain 1999;3 (5): 348-358.

Manchikanti L, Pampati V, Fellows B, Bakhit CE. The diagnostic validity and therapeutic value of lumbar facet joint nerve blocks with or without adjuvant agents; Curr Rev Pain 2000;4 (5) 37-44.

Pilleul F, Garcia J., Septic arthritis of the spine facet joint: early positive diagnosis; Joint Bone Spine 2000, 67 (3): 234-7.

Prather H., Hunt D.; Sacroiliac joint pain. Disease-A-Month. 2004; 50(12): 670-83.

Revel M, Poiraudeau S, Auleley GR, Payan C, Denke A, Nguyen M, Chevrot A, Fermanian J., Capacity of the clinical picture to characterize low back pain relieved by facet joint anesthesia. Proposed criteria to identify patients with painful facet joints; Spine 1998 Sep 15; 23 (18): 1972-6.

Other Contractor's Policies

Highmark Medicare Services Contractor Medical Directors 

 

Advisory Committee Meeting Notes

This policy does not reflect the sole opinion of the contractor or Contractor Medical Directors. Although the final decision rests with the contractor, this policy was developed in cooperation with advisory groups, which includes representatives from the appropriate specialty (ies).

CAC/IAC Distribution:  04/01/2008

Start Date of Comment Period

04/01/2008

End Date of Comment Period:

05/15/2008

Start Date of Notice Period

05/23/2008

Revision History

Revision History Number

L27512

Revision History Explanation

DatePolicy #Description

05/23/2008

L27512

Original LCD posted for notice. LCD to become effective 07/11/2008 for Maryland Part B, DCMA Part B and Delaware Part B.

04/01/2008

Draft J12-D35

Original LCD posted for comment.

Last Reviewed On

05/22/2008

Related Documents

This LCD has no Related Documents. 

LCD Attachments

There are no attachments for this LCD.           

© 2005-2008. All rights are reserved.